Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Matthew-Wood syndrome is a rare clinical entity including as main characteristics anophthalmia or severe microphthalmia, and pulmonary hypoplasia or aplasia.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 5 | Pulmonary hypoplasia, Agenesis of pulmonary vessels, Pulmonary artery atresia |
Kidneys and urinary system | 4 | Renal hypoplasia, Horseshoe kidney, Renal malrotation |
Growth and development | 3 | Severe short stature, Short stature, Intrauterine growth retardation |
Heart and blood vessels | 3 | Ventricular septal defect, Right aortic arch with mirror image branching, Atrial septal defect |
Brain and nerves | 2 | Profound intellectual disability, Profound global developmental delay |
Muscles | 2 | Low muscle tone (hypotonia), Generalized hypotonia |
Digestive system | 2 | Hypoplastic spleen, Multilobulated spleen |
Pregnancy and birth | 1 | Congenital diaphragmatic hernia |
STRA6 function has not been fully characterized.
Matthew-Wood syndrome is associated with mutations in the STRA6 gene on chromosome 15.
Genetic testing for STRA6 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Matthew-Wood syndrome has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 15 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Matthew-Wood syndrome.
107 publications have been identified in PubMed for Matthew-Wood syndrome. Kisho has analyzed 45 by research type. Research spans Review / Meta-Analysis (71%), Basic Science / Preclinical (11%), and Case Report / Case Series (7%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 32 | 71% |
Laboratory research | 5 | 11% |
Patient case studies | 3 | 7% |
Testing and diagnosis research | 2 | 4% |
Disease patterns and progression | 2 | 4% |
Other research | 1 | 2% |
Halperin Z (2026). [PMID: 40995837](https://pubmed.ncbi.nlm.nih.gov/40995837/). *Am J Med Genet A*. [Review / Meta-Analysis]
Richert Q (2026). [PMID: 41619932](https://pubmed.ncbi.nlm.nih.gov/41619932/). *Chest*. [Review / Meta-Analysis]
Yuan Y (2026). [PMID: 41782879](https://pubmed.ncbi.nlm.nih.gov/41782879/). *Front Immunol*. [Review / Meta-Analysis]
Van't Hoff C (2025). [PMID: 41308001](https://pubmed.ncbi.nlm.nih.gov/41308001/). *J Frailty Aging*. [Review / Meta-Analysis]
Löbel U (2025). [PMID: 39393841](https://pubmed.ncbi.nlm.nih.gov/39393841/). *AJNR Am J Neuroradiol*. [Diagnostic / Biomarker]
Sullivan MM (2025). [PMID: 40153327](https://pubmed.ncbi.nlm.nih.gov/40153327/). *Clin Exp Rheumatol*. [Review / Meta-Analysis]
Govindan A (2025). [PMID: 39624921](https://pubmed.ncbi.nlm.nih.gov/39624921/). *Otolaryngol Head Neck Surg*. [Review / Meta-Analysis]
Davenport M (2025). [PMID: 40519534](https://pubmed.ncbi.nlm.nih.gov/40519534/). *World J Pediatr Surg*. [Review / Meta-Analysis]
Hingar S (2025). [PMID: 40409799](https://pubmed.ncbi.nlm.nih.gov/40409799/). *Adv Genet*. [Review / Meta-Analysis]
Cardoso DL (2025). [PMID: 40393099](https://pubmed.ncbi.nlm.nih.gov/40393099/). *Eur J Radiol*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 2:21 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Matthew-Wood syndrome